Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | GUCY1B2 | O75343 | 8/20 | 0.41 |
| ▸ | GUCY1A2 | P33402 | 8/20 | 0.41 |
| ▸ | GUCY1A1 | Q02108 | 8/20 | 0.41 |
| ▸ | GUCY1B1 | Q02153 | 8/20 | 0.41 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.40 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.40 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.40 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.40 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.40 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | ATP4A | P20648 | 1/20 | 0.39 |
| ▸ | ATP4B | P51164 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7149054 | 0.81 | ADRA2A (0.56) | ADRA2AADRA2BADRA2CADRA1AHTR1A | |
| Hydrochloric Acid SCHEMBL3702932 | 0.77 | ATP4A (0.64) | ADRA2AADRA2BADRA2CADRA1APSEN1 | |
| SCHEMBL8322317 | 0.76 | ADRA2A (0.44) | ADRA2AADRA2BADRA2CADRA1APSEN1 | |
| SCHEMBL900661 | 0.73 | ADRA2A (0.55) | ADRA2AADRA2BADRA2CADRA1AHTR1A | |
| Hydrochloric Acid SCHEMBL3422321 | 0.72 | ADRA2A (0.54) | ADRA2AADRA2BADRA2CADRA1AHTR1A | |
| SCHEMBL795384 | 0.68 | ATP4A (0.62) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL6871464 | 0.68 | ADRA2A (0.49) | ADRA2AADRA2BADRA2CADRA1AHTR1A | |
| SCHEMBL8131625 | 0.68 | ATP4A (0.60) | ADRA2AADRA2BADRA2CADRA1AHTR1A | |
| SCHEMBL14570540 | 0.66 | PPARG (0.56) | CYP1A2CYP3A4CYP2C19PPARGCNR2 | |
| SCHEMBL7290793 | 0.66 | KDM4E (0.39) | ADRA2AADRA2BADRA2CADRA1AGUCY1B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130245241-A1 | Risperidone Immunoassay | SALADAX BIOMEDICAL INC. (US) | 2013-09-19 | — | — | US | disclosed |
| US-20130245241-A1 | Risperidone Immunoassay | SALADAX BIOMEDICAL INC. (US) | 2013-09-19 | — | — | US | disclosed |
| US-8450461-B2 | Risperidone immunoassay | SALADAX BIOMEDICAL INC. (US) | 2013-05-28 | — | — | US | disclosed |
| US-8450461-B2 | Risperidone immunoassay | SALADAX BIOMEDICAL INC. (US) | 2013-05-28 | — | — | US | disclosed |
| US-20120071636-A1 | RISPERIDONE IMMUNOASSAY | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (CN) | 2012-03-22 | — | — | US | disclosed |
| US-20120071636-A1 | RISPERIDONE IMMUNOASSAY | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (CN) | 2012-03-22 | — | — | US | disclosed |
| US-8088594-B2 | Risperidone immunoassay | SALADAX BIOMEDICAL INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-8088594-B2 | Risperidone immunoassay | SALADAX BIOMEDICAL INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-20110229979-A1 | RISPERIDONE IMMUNOASSAY | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (CN) | 2011-09-22 | — | — | US | disclosed |
| US-20110229979-A1 | RISPERIDONE IMMUNOASSAY | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (CN) | 2011-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110229979-A1 | RISPERIDONE IMMUNOASSAY | PRLHR, PA2G4, PRSS12 | ADRA2A 646/4885ADRA2B 598/4885ADRA2C 706/4885 |
| US-20120071636-A1 | RISPERIDONE IMMUNOASSAY | PRLHR, PA2G4, PRSS12 | ADRA2A 646/4885ADRA2B 598/4885ADRA2C 706/4885 |
| US-20130245241-A1 | Risperidone Immunoassay | PRLHR, PA2G4, PRSS12 | ADRA2A 646/4885ADRA2B 598/4885ADRA2C 706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.